We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SJM:NYSEThe J.M. Smucker Company Analysis

Data as of 2026-05-01 - not real-time

$98.03

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at $98.03, just below the identified resistance of $98.96 and well beneath its 20‑day SMA of 94.70, while the 50‑day and 200‑day SMAs sit at 101.02 and 104.51 respectively, signaling a bearish price structure. Momentum indicators are mixed: RSI hovers at 54 (neutral) and the MACD histogram is positive, yet the MACD line remains below its signal, reinforcing short‑term downside pressure. Valuation metrics compound the cautionary tone – the DCF‑derived fair value of $78.83 is far below the current market price, implying the stock is overvalued relative to intrinsic estimates. On the fundamentals side, revenue growth of 7% and a solid gross margin of 34% are offset by a negative profit margin of -14%, a trailing EPS of -$11.79, and a debt‑to‑equity ratio exceeding 140%, which raises solvency concerns. The dividend yield remains attractive at 4.49%, but an 86% payout ratio against weak earnings casts doubt on its sustainability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just below resistance with bearish SMA alignment
  • Mixed MACD signals but overall trend classified as bearish
  • Upcoming dividend ex‑date may provide short‑term support

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward EPS turning positive and analysts' median target near $120
  • Strong dividend yield in a defensive consumer staple sector
  • Revenue growth and stable cash flow supporting earnings recovery

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High leverage and negative ROE limit upside potential
  • Valuation above DCF fair value suggests limited long‑term price appreciation
  • Defensive sector exposure provides a floor but not a catalyst for growth

Key Metrics & Analysis

Financial Health

Revenue Growth7.00%
Profit Margin-14.07%
P/E Ratio9.8
ROE-20.68%
ROA4.80%
Debt/Equity143.20
P/B Ratio2.0
Op. Cash Flow$1.3B
Free Cash Flow$884.5M

Technical Analysis

TrendBearish
RSI54.2
Support$88.25
Resistance$98.96
MA 20$94.70
MA 50$101.02
MA 200$104.51
MACDBullish
VolumeStable
Fear & Greed Index90.89

Valuation

Fair Value$78.83
Target Price$117.81
Upside/Downside20.18%
GradeOvervalued
TypeValue
Dividend Yield4.49%

Risk Assessment

Beta0.04
Volatility20.24%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.